Patents by Inventor Alan Thomas Remaley

Alan Thomas Remaley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS (VLCPUFA) FOR IMPROVING RETINA/COGNITIVE FUNCTIONS AND ATHEROSCLEROSIS
    Publication number: 20250235421
    Abstract: The present invention is directed to methods for treating macular degeneration, atherosclerosis, fatty liver, obesity, and cognitive ability, and more specifically to methods for treating macular degeneration, atherosclerosis, fatty liver, obesity, and cognitive ability using very long chain polyunsaturated fatty acids having 24 to 40 carbon atoms.
    Type: Application
    Filed: July 7, 2023
    Publication date: July 24, 2025
    Inventors: Zhi-Hong Yang, Alan Thomas Remaley, Krishna Vamsi S. Rojulpote, Jingrong Tang, Isao Yamazaki, Hideaki Yamaguchi, Seizo Sato
  • ApoC-II mimetic peptides
    Patent number: 11827690
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: November 28, 2023
    Assignees: Novo Nordisk Inc., United State of America, As Represented by the Secretary, Dept. of Health and Human Services
    Inventors: Alan Thomas Remaley, Soumitra Shanker Ghosh, Madhav N. Devalaraja, Chih-Hung Lo, Denis O. Sviridov, Anna Wolska
  • ApoC-II Mimetic Peptides
    Publication number: 20210324043
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Application
    Filed: March 9, 2021
    Publication date: October 21, 2021
    Inventors: Alan Thomas REMALEY, Soumitra Shanker GHOSH, Madhav N. DEVALARAJA, Chih-Hung LO, Denis O. SVIRIDOV, Anna WOLSKA
  • ApoC-II mimetic peptides
    Patent number: 11136372
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: October 5, 2021
    Assignees: The United States of America, as represented by the Secretary, Dept. of Health & Human Services, Novo Nordisk A/S
    Inventors: Alan Thomas Remaley, Soumitra Shanker Ghosh, Madhav N. Devalaraja, Chih-Hung Lo, Denis O. Sviridov, Anna Wolska
  • ApoC-II Mimetic Peptides
    Publication number: 20200140522
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 7, 2020
    Inventors: Alan Thomas Remaley, Soumitra Shanker Ghosh, Madhav N. Devalaraja, Chih-Hung Lo, Denis O. Sviridov, Anna Wolska